LI-RADS v2018 CT/MRI中的LR-M:从最终用户角度综述影像标准、表现、挑战与未来方向
本文从最终用户角度综述LI-RADS v2018 CT/MRI中LR-M分类的影像标准、LR-M中肝细胞癌与非肝细胞癌恶性肿瘤的患病率,以及LR-M对预后和治疗结局的影响,并讨论最终用户面临的挑战与未来改进方向。
要点
- LR-M指可能或明确恶性但非肝细胞癌特异的肝脏病灶,包括不典型肝细胞癌、肝内胆管癌、混合型肝癌和转移瘤。
- LR-M的主要目的是在保持LR-5对肝细胞癌高特异度的同时,确保对所有肝脏恶性肿瘤的高敏感度。
- LR-M影像标准涵盖多种靶样和非靶样特征,最终用户对其理解常不如LR-4和LR-5。
核心结论
- LR-M在LI-RADS CT/MRI中具有关键作用,影响预后和治疗结局,但最终用户对其理解常不如LR-4和LR-5。
- 本文讨论了LR-M当前的影像标准及最终用户在LI-RADS v2018 CT/MRI中面临的挑战,并探索改进LR-M临床应用的未来方向。
研究设计与样本
- 综述,从最终用户角度撰写,检索范围与纳入文献原文未报告。
关键影像表现/征象
- LR-M影像标准涵盖多种靶样和非靶样特征。
- LR-M包括不典型肝细胞癌、肝内胆管癌、混合型肝癌和转移瘤等病因。
诊断标准与关键数值
- LR-M指可能或明确恶性但非肝细胞癌特异的肝脏病灶。
- LR-M的主要目的是确保对所有肝脏恶性肿瘤的高敏感度,同时保持LR-5对肝细胞癌的高特异度。
- LR-M的影像标准包括多种靶样和非靶样特征。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
LR-M is a category within the Liver Imaging Reporting and Data System (LI-RADS) that refers to liver observations that are probably or definitely malignant but are not specific to hepatocellular carcinoma (HCC). It includes etiologies such as atypical HCC, intrahepatic cholangiocarcinoma, combined hepatocellular cholangiocarcinoma and metastases. The primary aim of LR-M is to ensure a high sensitivity for detecting all hepatic malignancies while preserving a high specificity for HCC in LR-5. The imaging criteria for LR-M encompass a variety of targetoid and non-targetoid features. LR-M is often less well understood by end-users compared to more prominent categories such as LR-4 and LR-5, which have garnered greater attention and familiarity. In this review written from an end-user perspective, we examine the critical role that LR-M plays within LI-RADS for CT/MRI, the prevalence of HCC and non-HCC malignancies in LR-M, and demonstrate how LR-M can impact prognosis and treatment outcomes. We discuss the current imaging criteria for LR-M and the challenges faced by end-users in LI-RADS v2018 for CT/MRI. Finally, we explore future directions for improving the application of LR-M in clinical practice.
引用
- Low G, Pfanner T, Qian XJ, et al. LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective. Abdom Radiol (NY). 2025. PMID: 40810812. doi:10.1007/s00261-025-05132-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。